National Bank of Canada
FLGT icon

National Bank of Canada’s Fulgent Genetics FLGT Stock Holding History

National Bank of Canada’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.99K Buy
188
+10
+6% +$217 ﹤0.01% 2558
2025
Q4 		$4.67K Sell
178
-410
-70% -$10.6K ﹤0.01% 2445
2025
Q3 		$13.3K Hold
588
– – ﹤0.01% 2254
2025
Q2 		$11.7K Hold
588
– – ﹤0.01% 2314
2025
Q1 		$9.93K Sell
588
-121
-17% -$2.06K ﹤0.01% 2248
2024
Q4 		$13.1K Buy
709
+6
+0.9% +$117 ﹤0.01% 2269
2024
Q3 		$15.3K Sell
703
-165
-19% -$3.69K ﹤0.01% 1990
2024
Q2 		$17.4K Sell
868
-315
-27% -$6.58K ﹤0.01% 2002
2024
Q1 		$25.7K Sell
1,183
-220
-16% -$5.46K ﹤0.01% 1953
2023
Q4 		$41K Sell
1,403
-50
-3% -$1.34K ﹤0.01% 1827
2023
Q3 		$39K Hold
1,453
– – ﹤0.01% 1867
2023
Q2 		$53.8K Sell
1,453
-10
-0.7% -$349 ﹤0.01% 1759
2023
Q1 		$45.6K Sell
1,463
-400
-21% -$12.9K ﹤0.01% 1735
2022
Q4 		$55.5K Sell
1,863
-600
-24% -$21.5K ﹤0.01% 1713
2022
Q3 		$94K Hold
2,463
– – ﹤0.01% 1540
2022
Q2 		$134K Sell
2,463
-350
-12% -$19.2K ﹤0.01% 1500
2022
Q1 		$175K Buy
2,813
+1,100
+64% +$72.4K ﹤0.01% 1541
2021
Q4 		$172K Buy
+1,713
New +$151K ﹤0.01% 1501

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

National Bank of Canada's FLGT Position: Q1 2026 in Review

National Bank of Canada increased its Fulgent Genetics (FLGT) stake by 5.6% in Q1 2026, buying an estimated $217 and bringing the position to 188 shares worth $2.99K. The position accounts for ﹤0.01% of the portfolio, ranked #2558.

National Bank of Canada first reported a position in FLGT in Q4 2021 and has held it in 18 quarters since. The position peaked at $175K in Q1 2022. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • National Bank of Canada held 188 shares of Fulgent Genetics worth $2.99K as of Q1 2026.
  • National Bank of Canada bought 10 Fulgent Genetics shares in Q1 2026, an estimated $217.
  • Fulgent Genetics made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2558 holding.
  • National Bank of Canada first reported a position in Fulgent Genetics in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's Fulgent Genetics position peaked at $175K in Q1 2022.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.